Phase I

For over a decade and half, SIRO has helped the critical transition of a drug from preclinical to clinical stage. This is a vital step in the drug development process as many licensing deals in the pharmaceutical/ biotech sector occur during this stage. The value of a potential drug increases dramatically with a successful demonstration of safety and efficacy in the human population.

At this stage it is critical that you work with a partner that delivers timely, accurate data to enable you to make decisions about the safety and efficacy of your compound early in the clinical development cycle. The Phase I group at SIRO has worked with many emerging global pharmaceutical and biotech companies to guide potential drug candidates into First-in-Human trials and Proof-of-Concept studies. The group also maintains relationships with specialized Phase I units across the country.

Our services include
  • Phase I Studies in Oncology/DM
  • Project management
  • Feasibility and risk assessments
  • Site selection and prequalification
  • Clinical and medical monitoring
  • Site management
  • Recruitment support
  • Training for the project team
  • Protocol and CRF development

Phase I Project Management and Medical Services Experience
Oncology
  • Lung Cancer Study
  • Solid Malignant Tumors
  • Glioblastoma
  • Breast Cancer
  • Multiple Myeloma
  • Gastric Cancer

Respiratory
  • COPD

Ophthalmology
  • Macular Edema

Urology
  • Overactive Bladder
  • Neuropathic Bladder

Tropical Diseases
  • Kala Azar